Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2025-12-29 @ 10:15 PM
Study NCT ID:
NCT01137604
Status:
COMPLETED
Last Update Posted:
2022-09-29
First Post:
2010-06-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study in Subjects With Recurrent Malignant Glioma
Sponsor:
Eisai Inc.
Organization:
Study Overview
Official Title:
An Open-Label, Three-Cohort, Phase 2 Study of E7080 (Lenvatinib) in Subjects With Recurrent Malignant Glioma
Status:
COMPLETED
Status Verified Date:
2016-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An open-label phase 2, multicenter study in participants with recurrent malignant glioma.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: